NO172120C - Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler

Info

Publication number
NO172120C
NO172120C NO890245A NO890245A NO172120C NO 172120 C NO172120 C NO 172120C NO 890245 A NO890245 A NO 890245A NO 890245 A NO890245 A NO 890245A NO 172120 C NO172120 C NO 172120C
Authority
NO
Norway
Prior art keywords
isoxazols
preparation
pct
therapeutic active
analogy procedure
Prior art date
Application number
NO890245A
Other languages
English (en)
Norwegian (no)
Other versions
NO172120B (no
NO890245L (no
NO890245D0 (no
Inventor
Angelo Carenzi
Dario Chiarino
Davide Della Bella
Mauro Napoletano
Alberto Sala
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT20589/87A external-priority patent/IT1205014B/it
Priority claimed from IT20590/87A external-priority patent/IT1205015B/it
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NO890245L publication Critical patent/NO890245L/no
Publication of NO890245D0 publication Critical patent/NO890245D0/no
Publication of NO172120B publication Critical patent/NO172120B/no
Publication of NO172120C publication Critical patent/NO172120C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO890245A 1987-05-20 1989-01-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler NO172120C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT20589/87A IT1205014B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
IT20590/87A IT1205015B (it) 1987-05-20 1987-05-20 Composti ad attivita' nootropa
PCT/EP1988/000445 WO1988009330A1 (en) 1987-05-20 1988-05-19 Isoxazoles with nootropic activity

Publications (4)

Publication Number Publication Date
NO890245L NO890245L (no) 1989-01-19
NO890245D0 NO890245D0 (no) 1989-01-19
NO172120B NO172120B (no) 1993-03-01
NO172120C true NO172120C (no) 1993-06-09

Family

ID=26327590

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890245A NO172120C (no) 1987-05-20 1989-01-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler

Country Status (10)

Country Link
US (1) US4985428A (de)
EP (1) EP0317588B1 (de)
JP (1) JPH02500365A (de)
AT (1) ATE65997T1 (de)
AU (1) AU599809B2 (de)
DE (1) DE3864124D1 (de)
DK (1) DK4389A (de)
FI (1) FI89266C (de)
NO (1) NO172120C (de)
WO (1) WO1988009330A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
DE10105040A1 (de) * 2001-02-05 2002-08-14 Tell Pharm Ag Hergiswil Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
ITMI20042187A1 (it) * 2004-11-16 2005-02-16 Zambon Spa Derivati isossazolici per allievare il dolore neiropatico

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2024M (fr) * 1961-02-01 1963-09-23 Shionogi & Co Utilisation de dérivés de l'isoxazole pour le traitement des maladies mentales et particulierement des dépressions nerveuses.
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
NO172120B (no) 1993-03-01
AU1786988A (en) 1988-12-21
EP0317588A1 (de) 1989-05-31
EP0317588B1 (de) 1991-08-07
WO1988009330A1 (en) 1988-12-01
DE3864124D1 (de) 1991-09-12
FI890173A (fi) 1989-01-13
ATE65997T1 (de) 1991-08-15
FI890173A0 (fi) 1989-01-13
NO890245L (no) 1989-01-19
AU599809B2 (en) 1990-07-26
NO890245D0 (no) 1989-01-19
DK4389D0 (da) 1989-01-06
FI89266C (fi) 1993-09-10
FI89266B (fi) 1993-05-31
DK4389A (da) 1989-01-06
JPH02500365A (ja) 1990-02-08
US4985428A (en) 1991-01-15

Similar Documents

Publication Publication Date Title
GR3023825T3 (en) Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
NO170803C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater samt forbindelser til bruk ved fremgangsmaaten
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
NO171412C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater
DK122391A (da) Terapeutisk aktiv, substitueret benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
NO870049L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
NO891703L (no) Farmasoeytiske sammensetninger for behandling av psoriasis.
ATE87476T1 (de) Fluessige orale formulierung.
NO172120C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoxazoler
DK149590C (da) Analogifremgangsmaade til fremstilling af 2-aryl-3,4-diaza-bicyclo(4,1,0)hepten-(2)-on-(5)-forbindelser
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK47988A (da) Substituerede 3-phenyl-7h-thiazolooe3,2-baaoe1,2,4aatriazin-7-oner, deres fremstilling og anvendelse som laegemiddel, samt ved fremstillingen anvendelige mellemprodukter
NO821083L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfantridin-derivater
SE8703308D0 (sv) Therapeutic agent for the treatment of disorders associated with cerebral ischemia
DK48489D0 (da) Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
ES2039255T3 (es) Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.
NO891678D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
NO890502L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etanolamin-derivater.
DK98788D0 (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler
NO170017C (no) Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater